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Background: We previously demonstrated the existence of two distinct subsets of T cell receptor
(TCR)ab+CD8ab+ single positive (SP) cells in human postnatal thymus which express the chemokine
receptor CCR7 or CXCR3 and migrate in vitro in response to their specific ligands.
Aim: To investigate whether these two CD8+ thymocyte subsets had distinct peripheral colonisation.
Methods: TCRab+CD8+ SP cells were obtained from normal postnatal thymus, mesenteric lymph node
(LNs), small bowel, and peripheral blood (PB) specimens. Cells were then evaluated for expression of
surface molecules, cytolytic potential, telomere length, and profile of cytokine production.
Results: CD8+CCR7+CXCR32 thymocytes exhibited CD62L, in common with those which localise to LNs.
In contrast, CD8+CCR72CXCR3+ thymocytes lacked CD62L but exhibited CD103, similar to
intraepithelial lymphocytes (IELs) present in the gut mucosa where the CXCR3 ligand, CXCL10, and the
CD103 ligand, E-cadherin, are highly and consistently expressed. In addition, thymocytes and gut
CD8+CXCR3+CD103+ cells showed comparable telomere length, which was higher than that of PB
CXCR3+CD8+ T cells. However, both of these populations contained perforin and granzyme A, and
displayed the ability to produce interferon c and interleukin 2. Of note, CXCR3 deficient, in comparison
with wild-type C57Black/6, mice showed decreased proportions of CD3+CD8ab+ and increased
proportions of CD3+CD8aa+ lymphocytes at gut level. Moreover, adoptive transfer of CD3+CD8ab+
thymocytes from wild-type into CXCR3 deficient mice resulted in a significant increase in CD3+CD8ab+
T cells in the gut mucosa but not in other tissues.
Conclusions: The results of this study demonstrate the existence of a previously unrecognised subset of
TCRab+CD8ab+ SP CXCR3+CD103+ thymocytes which share phenotypic and functional features with
CD8+ IELs, thus suggesting the possibility of their direct colonisation of the gut mucosa.
C
hemokines and their receptors play an essential role in
the trafficking of lymphocytes during their develop-
ment into primary lymphoid organs,1 their migration to
peripheral lymphoid organs,2 and their recruitment into
inflamed tissues as a consequence of antigen activation.3
Recirculating lymphocytes are recruited from the blood-
stream into lymphoid tissues via selective interactions with
high endothelial venules (HEV). Lymphocyte recognition of
HEV involves a multistep adhesion cascade in which different
selectins, chemokines, and integrins participate in the
primary adhesive interactions, as well as in firm arrest.
There is convincing evidence to suggest that the chemokines
CCL19 and CCL21, and their specific receptor, CCR7,
expressed on naı¨ve T lymphocytes, are involved in this
process.4–7 Indeed, mice deficient in CCL21 and CCL19
production have severe defects in T cell homing to peripheral
lymphoid organs, as do mice with targeted deletion of
CCR7.8–10
The presence of CCL21 and CCL19 has also been demon-
strated in murine and human thymus where these chemo-
kines exert chemotactic activity on both mature single
positive (SP) CD4+ and CD8+ thymocytes, thus favouring
their migration into the circulation.11 12 Apart from CCR7,
circulating naı¨ve T cells are known to express only two other
chemokine receptors, CCR9 (expressed by a small subset of
naı¨ve T cells) and CXCR4 (broadly expressed), both of which
also bind homeostatic chemokines. Thus far, a role for CCR9
in the entry of T cells into lymph nodes (LNs) has not been
demonstrated. The ligand for CCR9 is CCL25, which is
selectively expressed in the small intestine,13 14 raising the
possibility that this chemokine is involved in the trafficking
of naı¨ve CCR9+ T cells to lymphoid structures of the small
intestine. However, it is also possible that the presence of
CCR9 in naı¨ve T cells is simply a remnant of development in
the thymus, as CCR9 is broadly expressed by thymocytes.13 15
In contrast, CXCR4 does appear to contribute to T cell entry
into LNs. Indeed, CXCL12 (the ligand for CXCR4) has been
shown to promote transendothelial migration of T cells across
HEVs.16 Hence CCR7 and CXCR4 may cooperate in the task of
naı¨ve T cell recruitment into LNs. Of note, other chemokine
receptors with expression on naı¨ve T cells have not yet been
identified. CXCR3 binds the chemokines CXCL10, CXCL9,
and CXCL11, is expressed on the surface of different cell
types, including activated T cells and natural killer cells, and
Abbreviations: SP, single positive; PB, peripheral blood; IELs,
intraepithelial lymphocytes; HEV, high endothelial venules; mAbs,
monoclonal antibodies; LNs, lymph nodes; TCR, T cell receptor; IL,
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subsets of inflammatory dendritic cells, macrophages, and B
cells, and its expression on T lymphocytes is upregulated by
inflammation.3
Recently, we discovered the presence in human postnatal
thymus of a subset of T cell receptor (TCR)ab+CD8ab+ SP
cells which express CXCR3 and migrate in vitro in response to
CXCL10, CXCL9, and CXCL11, but not to CCL19 or CCL21.17
Thymic TCRcd and CD32CD56+ (natural killer-like) cells
also showed similar behaviour.17 In this study, we hypothe-
sised that the two CD8+ thymocyte subsets (CCR7+ or
CXCR3+) have distinct peripheral colonisation. Therefore, we
assessed the presence of CCR7 and CXCR3, as well as of other
phenotypic and functional markers, in TCRab+CD8ab+ SP
thymocytes and compared the phenotype of these cells with
that of CD8ab+ T cells present in different tissues, such as
LNs, peripheral blood (PB), and small bowel. The results
showed that SP CD8+ thymocytes expressing CXCR3 repre-
sent a distinct population of cells that selectively colonise to
the lymphoid structures of the small intestine.
MATERIAL AND METHODS
Human specimens
Normal postnatal thymus specimens were obtained from 11
children aged between five days and three years, and from
one 42 year old male who underwent corrective cardiac
surgery. Normal mesenteric LNs, uninvolved small bowel
specimens, and PB lymphocytes were all obtained from 18
patients who underwent surgery because of colon cancer
(eight patients) or Crohn’s disease (10 patients). Additional
PB samples were obtained from 13 healthy volunteers. All
patients gave informed consent. The procedures followed in
the study were in accordance with the ethical standards of
the Regional Committee on Human Experimentation which
approved the study.
Animals
CXCR3 deficient mice backcrossed 10 generations into the
C57Black/6 background have been described previously.18
Wild-type C57Black/6 mice were used as controls. Mice were
maintained under specific pathogen free conditions until use.
Reagents
Purified anti-CD8a, as well as the fluorochrome conjugated
anti-CD3, anti-CD4, anti-CD62L, anti-CD103, anti-CD20,
anti-TCRcd, anti-interleukin (IL)-2, anti-IL-4, anti-IL-10,
anti-IL-13, anti-interferon c (IFN-c), anti-perforin, and
anti-granzyme A monoclonal antibodies (mAbs) were pur-
chased from Becton Dickinson (San Jose, California, USA);
anti-CD8b and anti-E-cadherin mAbs were obtained by
Beckman Coulter (Brea, California, USA). Goat antimouse
IgG Abs conjugated with magnetic beads were obtained from
Miltenyi Biotec (Bisley, Germany). Purified fluorochrome
conjugated isotype control and fluorochrome conjugated
anti-isotype mAbs were purchased from Southern
Biotechnology Associates (Birmingham, Alabama, USA).
Purified and PE conjugated anti-CXCR3, anti-CCR9, and
anti-CCR7 mAbs were obtained from R&D (Minneapolis,
Minnesota, USA). Anti-CXCL10 rabbit polyclonal Ab was
from Peprotech (London, UK). Fluorochrome conjugated
antimouse CD4, CD8a, and CD8b mAbs were purchased from
Serotec (Oxford, UK).
Preparation of cell suspensions and isolation of IELs
Thymus fragments were gently passed through a stainless
steel mesh (Medimachine; Becton Dickinson) to obtain single
cell suspensions from which mononuclear cells (MNC) were
separated by centrifugation on Ficoll-Hypaque gradient.
Specific isolation of intraepithelial lymphocytes (IELs) was
performed as follows: the epithelial layer was removed using
phosphate buffered saline (PBS) calcium and magnesium
free supplemented with 1 mM EDTA and 1 mM DTT (Sigma
Chemical Co, St Louis, Missouri, USA). After continuous
agitation for one hour at 37 C˚, single cell suspension was
pelleted from the supernatant and washed once with PBS
supplemented with 5% fetal calf serum. MNC were then
separated by centrifugation on Ficoll-Hypaque gradient.
Positive selection of CD8+ T cells
Positive selection of CD8+ T cells was performed by high
gradient magnetic cell sorting, as described elsewhere.11
Briefly, PBMNC or CD4 depleted thymocytes were incubated
with an anti-CD8 mAb, extensively washed, and then further
incubated with a microbead conjugated goat antimouse
polyclonal Ab (Milteny Biotec GmbH, Bergisch Gladbach,
Germany). After washing, cells were separated on a LS+
column. Purity of recovered cells was consistently higher
than 98%.
Adoptive cell transfer in mice
Thymocytes obtained from five wild-type C57Black/6 mice
were depleted of CD4+ T cells using a microbead conjugated
anti-CD4 mAb (Milteny Biotec GmbH). CD4+ cell depleted
thymocyte suspensions were then incubated with a
microbead conjugated anti-CD8 mAb and, after washing,
separated on a LS+ column (Milteny Biotec GmbH). Purity of
recovered cells was consistently higher than 98%. The
majority of CD8+ thymocytes (.98%) were
CD3+TCRabCD8ab cells. CD8+ cells were counted and
26107 cells were injected into the tail vein of three singenic
CXCR3 deficient mice. After 24 hours, mice were sacrificed
and gut, spleen, liver, and PB were monitored with flow
cytometry for CD8ab and CD8aa content.
Flow cytometric analysis
Flow cytometric analysis on cell suspensions was performed
as detailed elsewhere.11 Assessment of cytoplasmic perforin
and granzyme A expression was performed according to the
manufacturer’s instructions (BD Biosciences). Flow cyto-
metric analysis of cytokines synthesis at the single cell level
was performed as detailed elsewhere.19 Cells were analysed
on a BDLSR cytometer using CellQuest software (BD
Biosciences).
Determination of telomere length
Telomere staining was performed using the Dako Telomere
PNA Kit/FITC, according to manufacturer’s instructions
(Dako, Glostrup, Denmark).
Table 1 CXCR3 and/or CCR7 expression by CD8+ T
cells
Cell source No







Thymus 11 13 (5)* 79 (3) ,111
PB 31 39 (8) 11 (4)** 42 (9)
Lymph node 18 14 (3)` 17 (5) 64 (8)***
Gut 18 88 (7)1 3 (2)`` ,1
CXCR3 and CCR7 expression levels were assessed by flow cytometry in
CD3+CD8+ gated cells.
Values are mean (SEM) of positive cells.
PB, peripheral blood.
* v , p,0.05; * v `, NS; * v 1, p,0.01;  v `, p,0.05;  v 1, p,0.01;
` v 1, p,0.01;  v **, p,0.01;  v , p = 0.01;  v ``, p,0.01; ** v
, NS; ** v ``, NS;  v ``, p,0.05; 11 v , p,0.01; 11 v ***,
p,0.01; 11 v , NS;  v ***, NS;  v , p,0.01; *** v ,
p,0.01.
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Immunohistochemistry
Immunohistochemical staining was performed on 10 mm
cryostat sections, fixed in 4% paraformaldehyde for 20 min-
utes, or in acetone for 10 minutes. Sections were subse-
quently exposed to 0.3% hydrogen peroxide-methanol
solution to quench endogenous peroxidase activity. After
30 minutes of preincubation with normal horse serum
(Vectastain ABC kit; Vector Laboratories, DBA, Milan,
Italy), sections were layered for 30 minutes with anti-
CXCL10 (10 mg/ml) or anti-CK (2 mg/ml), anti-E-cadherin
(10 mg/ml), anti-CXCR3 (10 mg/ml), or anti-CD8b chain
(10 mg/ml) Abs, followed by biotinylated antimouse or
antirabbit IgG Ab, and the avidin-biotin-peroxidase complex
(Vectastain ABC kit). 3-Amino-9-ethylcarbazole (AEC;
Sigma) was used as a peroxidase substrate. Finally, sections
were counterstained with Gill’s haematoxylin and mounted
with Kaiser’s glycerol gelatin. All incubations were performed
at room temperature. As negative control, primary Ab was
replaced with an isotype matched Ab with irrelevant
specificity. Double immunostaining was performed using
the avidin-biotin-peroxidase system with two different
substrates. To identify two different proteins on the same
specimen, AEC (red colour) and Vector SG (bluish grey)
substrates were used. After double immunostaining, sections
were mounted with Kaiser’s glycerol gelatin.
Statistical analysis
Statistical analysis was performed using the Student’s t test
and the ANOVA test.
RESULTS
Analysis of CXCR3 and CCR7 expression by
TCRab+CD8+ SP T cells in human thymus and in other
tissues
In a previous study, we demonstrated that TCRab+CD8+ SP
cells present in postnatal human thymus, unlike TCRabCD4+
SP cells which migrate only in response to CCL19 or CCL21,
could migrate also in response to CXCL10, CXCL9, or
CXCL11.17 Virtually all of these cells expressed the CD8ab
heterodimer.17 To establish whether CD8ab+ thymocytes
responding to CCL19 and CCL21 or to CXCL10, CXCL9, and
CXCL11 were distinct or overlapping subsets, expression of
the corresponding receptors, CCR7 and CXCR3, was con-
temporaneously assessed on TCRab+CD8ab+ SP thymocytes
from 11 postnatal human thymuses. In all cases, CXCR3
appeared to be expressed by smaller subset than, but clearly
distinct from, CD8ab+ SP thymocytes expressing CCR7
(table 1, fig 1). The same results were obtained when thymic
specimens derived from one 42 year old subject were assessed
(data not shown). We asked therefore whether a similar
dichotomy could also be observed at the level of mature CD8+
T cells from different human tissues. In LNs, more than 80%
of CD8+ T cells expressed CCR7 and the majority also CXCR3
(table 1, fig 1). In PB, despite great variability at the
individual level, there were three populations of CD8+
T cells, one of which expressed both CXCR3 and CCR7 and
the other two CXCR3, or CCR7 alone (table 1, fig 1). In
normal small bowel specimens from all 18 subjects exam-
ined, the vast majority (.80%) of recovered T cells were
CD8+ and all expressed the CD8ab heterodimer (data not
shown) and exhibited CXCR3, but no CCR7 (table 1, fig 1), as
previously described.20
CD8+CXCR3+ thymocytes have phenotypic and
functional properties different from CD8+CCR7+
thymocytes
To further investigate the meaning of the above mentioned
findings, the two CD8+ thymocyte subsets (CXCR3+CCR72
and CCR7+CXCR32) were assessed for expression of other
phenotypic and functional markers, such as CD62L, CD103,
perforin, and granzyme A. Virtually all CXCR3+CD8+
thymocytes were CD62L2 and part of them showed expres-
sion of both CD103 (,30%) and perforin (,28%) (fig 2). Of
note, more than 50% of perforin expressing cells also
exhibited CD103 (fig 2, insert). In contrast, virtually all
CCR7+CD8+ thymocytes were CD62L+ but they did not
express CD103 or perforin (fig 2). We therefore assessed the
same markers on CD8+ T cells from LNs, PB, and small
bowel. As shown in fig 2, CD8+ T cells present in the normal
gut showed a phenotype quite similar to CXCR3+CD8+
thymocytes (CXCR3+CD62L2CD103+), differing only
because of a more pronounced presence of perforin, whereas
virtually all CCR7+CD8+ T cells (both CXCR3+ and CXCR32)
from LNs exhibited high CD62L, but no CD103, and poor
perforin expression (fig 2). CXCR3+CCR7+CD8+ T cells
present in PB were CD62L+, but CD1032, and showed no
perforin expression. In contrast, CXCR3+CCR72 circulating
CD8+ T cells were CD62L2, a small proportion of them
(,1%) expressed CD103, whereas all exhibited strong
perforin expression (fig 2). The distribution of granzyme A
in the same tissues appeared to be quite similar to that of
perforin (data not shown).
CXCR3+CD8+ thymocytes share phenotypic and
functional properties with gut IELs
Expression of both CXCL10 and CXCR3 was then investigated
in normal small bowel specimens using double staining
Immunohistochemistry. High CXCL10 expression was
































Figure 1 Different distribution of CXCR3 and CCR7 on T cell receptor
(TCR)ab+CD8+ single positive T cells from thymus, lymph nodes,
peripheral blood lymphocytes (PBL), and gut. Mononuclear cell (MNC)
suspensions from tissue fragments and peripheral blood were obtained
as described in material and methods. In the case of thymus derived
MNC, CD4+CD8+ DP thymocytes were first removed by high gradient
magnetic cell sorting, as described in material and methods. The
remaining cells were then contemporaneously stained with anti-CCR7,
anti-CXCR3, anti-CD3, and anti-CD8 fluorochrome conjugated
monoclonal antibodies, and analysed on a BD-LSR cytometer. All plots
represent CD3+CD8+ gated cells.
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3B) where it colocalised with E-cadherin (fig 3C). In the
same tissue sections, high proportions of intraepithelial CD8+
T cells expressing CXCR3 were observed (fig 3D). As
CXCL1213 and CCL2514 21 22 have also been implicated in the
chemoattraction of T cells to the gut mucosa, expression of
the respective receptors, CXCR4 and CCR9, by CXCR3+CD8+
T cells was also investigated. Although a fraction of
CXCR3+CD8+ gut T cells expressed CXCR4 (mean 43%
Figure 2 Assessment of CD62L, CD103, and perforin on CXCR3+CCR72CD8+ and on CXCR32CCR7+CD8+ cells. T cells from the thymus, gut,
lymph node, and peripheral blood lymphocytes (PBL) were contemporaneously stained with anti-CD103 (or anti-CD62L, or anti-perforin), anti-CXCR3,
anti-CCR7, and anti-CD8 fluorochrome conjugated monoclonal antibodies, and analysed on a BD-LSR cytometer. In the case of perforin staining, cells
were previously fixed (for additional details, see material and methods). All histograms represent CD8+ gated cells. The insert plot was performed on
CD8+ SP purified thymocytes (see material and methods) and stained for CXCR3, CCR7, CD103, and perforin.
Figure 3 CXCL10 and E-cadherin colocalisation in intestinal epithelial cells and CXCR3 expression by intestinal T cell receptor (TCR)ab+CD8+
intraepithelial lymphocytes (IELs). (A) CXCL10 expression by intestinal epithelial cells. Sections of morphologically and histologically normal small
bowel were stained with anti-CXCL10 polyclonal monoclonal antibody (red colour) and counterstained with Gyll’s haematoxylin (blue colour) (6100).
(B) Double label immunohistochemistry for CXCL10 (red colour) and CK (bluish-grey colour) showing CXCL10 expression by intestinal epithelial cells.
No counterstain was applied (6250). (C) Double label immunohistochemistry showing coexpression of CXCL10 (red colour) and E-cadherin (bluish-
grey colour) in intestinal epithelial cells. No counterstain was applied (6400). (D) Double label immunohistochemistry showing CXCR3 expression
(bluish-grey colour) by CD8ab+ IELs (red colour). No counterstain was applied (6400).
964 Annunziato, Cosmi, Liotta, et al
www.gutjnl.com
 group.bmj.com on December 13, 2010 - Published by gut.bmj.comDownloaded from 
(SEM 8%) in six bowel specimens analysed), the same
receptor was also found in the majority (78% (SEM 13%) in
10 PB analysed) of PB CD8+ T cells, suggesting that this
receptor was not critical for the selective homing of
CXCR3+CD8+ lymphocytes to the gut. On the other side,
CCR9 was found to be expressed in the thymus by the CCR7+,
but not by the CXCR3+, CD8+ subset, and was virtually
absent in CXCR3+CD8+ intestinal T cells (fig 4A).
Accordingly, the small subset of CD103+CD8+ circulating T
cells, which neither expressed CCR7 nor CD62L, also lacked
CCR9 (fig 4B). In contrast, CCR9+ cells were detected in the
CD20+ IEL population (data not shown).
Telomere length and profile of cytokine production of
CXCR3+CD8+ cells from the thymus, gut, and PB were then
compared. Analysis of telomere length of CXCR3+CD8+
thymocytes was comparable with that of both CCR7+CD8+
thymocytes and CXCR3+CD8+ gut IELs while telomere length
of CXCR3+CD8+ PB lymphocytes was usually lower (fig 5A).
Finally, both CXCR3+CD8+ thymocytes and CXCR3+CD8+
IELs showed the ability to produce both IL-2 and IFN-c, but
not IL-4, IL-10, or IL-13, in response to polyclonal stimulation
whereas under the same experimental conditions
CCR7+CD8+ thymocytes produced only small amounts of
IL-2 (fig 5B). These findings suggest the possibility that
CXCR3+CD8+ thymocytes represent a distinct subset able to
directly migrate and colonise the gut mucosa.
Reduced proportions of TCRab+CD8ab+ T lymphocytes
in the gut of CXCR3 gene deficient mice
It is known that there are two major populations of
CD3+CD8+ IELs in the mouse, one of which (CD8aa+)
consists of TCRab+ and TCRcd+ lymphocytes and the other
(CD8ab+) is represented only by TCRab+ lymphocytes.23
To provide further evidence that CXCR3 may play a role in
the migration of TCRab+CD8ab+ thymocytes to the gut,
proportions of CD3+CD8aa+ or CD3+CD8ab+ T cells in the
gut and PB of both CXCR3 gene deficient and wild-type mice
were evaluated. There were no differences in the proportion
of the two populations in the PB of CXCR3 deficient versus
wild-type animals (fig 6A). In contrast, the proportions of
CD3+CD8aa+ T cells were significantly increased whereas
those of CD3+CD8ab+ T cells were significantly reduced, in
CXCR3 deficient in comparison with wild-type animals
(fig 6B). CD3+CD8+ thymocytes (mainly composed of
CD8ab+ cells) obtained from wild-type mice were then
transferred to CXCR3 gene deficient mice, and after one day
the proportions of CD3+CD8ab+ T cells present in the gut,
liver, spleen, and PB of these animals were compared with
those present in untreated mice. As shown in fig 6C, there
was a significant increase in CD3+CD8ab+ T cells in the gut,
but not in the PB, spleen, or liver of adoptively transferred
mice.
DISCUSSION
In this study, we demonstrated that TCRab+CD8ab+ SP
T cells expressing CXCR3 in human postnatal thymus were
distinct from those expressing CCR7 and also exhibited
different phenotypic and functional markers. CXCR3+CD8+
thymocytes lack CD62L, but express CD103, and part of them
also possesses perforin and granzyme A. In contrast,
CCR7+CD8+ thymocytes express CD62L, but lack CD103,
perforin, and granzyme A. CD103, which is the aE chain of
aEb7 integrin, has recently been found to define a distinct
subset of naı¨ve CD8+ T cells in the periphery, showing an age
related decline in frequency which is significantly enhanced
by thymectomy, thus suggesting their nature of recent thymic
emigrants.24 Of note, by assessing the same markers in
different human tissues, we found that the great majority of
CD8+ T cells present in the small bowel showed a pheno-
type nearly identical to CXCR3+CD8+ thymocytes
(CD62L2CD103+ perforin positive), whereas lymph nodes
contained CD8+ T cells showing features more similar to the
CCR7+CD8+ thymocyte subset (CD62L+CD1032 perforin
negative), although part of them expressed both CXCR3
and CCR7.
Based on these data we hypothesise that the two CD8+
thymocyte subsets (CXCR3+ or CCR7+) may have a different
destiny and, therefore, also a different functional meaning.
CCR7 expressing CD8+ thymocytes certainly colonise LNs
through HEV. Coexpression of CXCR3 and CCR7 on a
proportion of CD8+ LN T cells suggests that they can acquire
CXCR3 after entering LNs and following their local activation
by a specific antigen. It is indeed known that the great
majority of T cells acquire CXCR3 in response to antigen
activation, then recirculate, and are attracted by CXCR3











































































Figure 4 Assessment of CCR9 on thymus, gut, and peripheral blood
(PBL) T cell receptor (TCR)ab+CD8+ T lymphocyte subsets. (A) Thymus
and gut purified TCRab+CD8+ T lymphocytes were contemporaneously
stained with anti-CXCR3 or anti-CCR7 and anti-CCR9 monoclonal
antibodies. (B) TCRab+CD8+ PB T cells were assessed for expression of
CD103 and CCR9, CXCR3, CCR7, or CD62L.
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to IFN-c and other cytokines.3 This can account for the
presence of high numbers of CXCR3+CCR7+CD8+ T cells in
PB. However, PB usually contained remarkable proportions
of CD8+ T cells expressing CXCR3, but no CCR7. One
explanation may be that these cells reflect the traffic into
the circulation of CXCR3+CD8+ thymocytes. However, this
possibility is unlikely as the majority of circulating
CXCR3+CCR72CD8+ T cells differed from CXCR3+CD8+
thymocytes because of the lack of CD103 and a short
telomere length compared with T cells which have undergone
several cycles of cell division.25 26 Thus it is more reasonable to
believe that the majority of CXCR3+CCR72 CD8+ T cells
present in adult PB are T lymphocytes activated in peripheral
lymphoid tissues.27 28 Accordingly, we found that
CCR7+CXCR32CD8+ umbilical cord blood T cells could be
induced to express CXCR3 after polyclonal stimulation in
vitro and to lose CCR7, but not CXCR3, following prolonged
activation (data not shown).
We also hypothesise that CXCR3+CD8+ thymocytes,
because of their lack of CCR7, cannot enter peripheral
lymphoid tissues through HEV, but migrate directly to gut
mucosa where they colonise as IELs. A major role for CCR9
and its ligand CCL25 in the organisation of regional
immunity at the level of the small intestinal compartment
has been reported in both mice and humans.14 21 22
Nevertheless, we found that CCR9 was expressed at the
thymus level by CXCR32CCR7+, but not by CXCR3+CCR72,
CD8+ T cell subset and was present in a small minority of
human gut CXCR3+CD8+ IELs. Secondly, both thymic and
circulating CD8+CXCR3+CD103+ T cells did not express
CCR9. Thirdly, at least in our hands, the only gut IEL subset
which consistently expressed CCR9 was represented by B
lymphocytes. Thus the reasons for the discrepancies between
these data and the results of previous studies14 21 22 remain
unclear. On the other hand, the present results are consistent
with those obtained in mice lacking CCR9, or in mice
reconstituted with bone marrow derived haematopoietic
progenitor cells that were transduced with a genetically
modified CCL25 intrakine expressing gene and exhibit a
reduction in TCRcd+, but not TCRab+, gut IELs.29–31 This
suggests a role for other chemokine receptors in the
recruitment of the latter cell type. Accordingly, it has recently
been shown that the majority of mouse TCRcd+ cells express
CCR9 whereas only a minority of CD8+ cells do.32 Moreover,
in agreement with the finding reported here that CCR9 was
expressed on intestinal B cells, it has recently been shown
that the interaction between CCR9 and its ligand CCL25 is
crucial for recruitment to, and permanence in, the intestinal
mucosa of IgA secreting B lymphocytes.33 34 Another chemo-
kine possibly involved in the migration of the CXCR3+CD8+
thymocyte subset to gut mucosa may be CXCL12, which has
been found to be produced by intestinal epithelial cells.13
However, this possibility is unlikely, inasmuch as only a
proportion of CXCR3+CD8+ gut T cells expressed CXCR4. The
aEb7 integrin (identified by CD103) has been found to be
essential for IEL localisation,35 inasmuch as it mediates
adhesion of T cells to epithelial cells via their interaction with
E-cadherin36–38 and to microvascular endothelial cells via the
interaction with another still unknown ligand.39 Accordingly,
epithelial cells from normal small bowel expressed high
concentrations of both CXCL10 and E-cadherin, and in the
same specimens CXCR3 was found to be localised mainly at
the level of CD8+ IELs. Constitutive production of high
amounts of both CXCL10 and CXCL9 by intestinal epithelial
cells has been reported both in vivo40 and in vitro.41 Likewise,
CXCR3 expression by virtually all fresh intestinal IELs has
already been observed,39 thus supporting the view that
interactions between CXCR3 and its ligands may play an
essential role in the colonisation of CXCR3+ thymocytes to
the gut mucosa.
CXCR3 expression by gut IELs had been attributed to
chronic activation of these cells by luminal pathogens.39 The
results of this study do not allow us to draw definitive
conclusions on the naı¨ve or memory effector phenotype of
CXCR3+CD103+CD8+ T cells present in the gut. In agreement



































































































Figure 5 Assessment of telomere length and profile of cytokine production by the thymus, peripheral blood (PBL), or gut derived CD8+ T lymphocytes.
(A) Telomere length of CD8+ cells from thymus (CXCR3+ and CCR7+), gut (CXCR3+), and PBL (CXCR3+). CD8+CXCR3+ and CD8+CCR7+ cells were
positively selected by high gradient magnetic cell sorting from PB and gut mononuclear cell suspensions or thymocytes depleted from DP CD4+CD8+
cells, and then stained with a fluorescein conjugated telomere specific PNA probe, as described in material and methods. Cells of the tetraploid 1301
cell line were used as control cells having long telomeres. White histograms represent the unstained samples, black histograms the stained samples, and
grey histograms the 1301 cell line. (B) Profile of cytokine production of CD8+ T cells from the thymus (CXCR3+ and CCR7+) and gut (CXCR3+), as
assessed by intracellular detection by flow cytometry following polyclonal stimulation with PMA plus ionomycin. Columns represent mean (SEM) values
of four separate experiments. IL, interleukin; IFN-c, interferon c.
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T cells prevalently exhibit a memory/effector phenotype,42–44
we found that both CXCR3+CD103+CD8+ T cells from the
thymus and gut, unlike CCR7+CD8+ thymocytes, expressed
activation markers, such as CD69 and CD45RO (data not
shown). Furthermore, unlike CCR7+CD8+ thymocytes that
do not produce any type of cytokine, CXCR3+CD8+ cells from
both the thymus and gut showed the ability to produce IL-2
and IFN-c in response to polyclonal stimulation. On the other
hand, analysis of the TCRVb repertoire did not reveal
enrichment for any Vb in gut IELs, as well as no significant
differences not only between PB and gut lymphocytes but
also between CXCR3+ and CCR7+ thymocytes, suggesting
that no oligoclonal expansion due to repeated antigen
stimulation had occurred (data not shown). Moreover, the
great majority of intestinal CXCR3+CD8+ T cells exhibited a
telomere length which was greater than that of CXCR3+CD8+
PB T cells and rather comparable with CXCR3+CD8+, and
more importantly with CCR7+CD8+, thymocytes, thus
suggesting that even these cells had not undergone repeated
cycles of cell division.
Strong support for the hypothesis of a major role of the
interaction between CXCR3 and its ligands (mainly CXCL10)
in the colonisation of CXCR3+CD8+ thymocytes to the gut
mucosa was provided by experiments performed in CXCR3
deficient mice. These animals showed increased proportions
of CD3+CD8aa+ (which include both TCRab and TCRcd
cells), and decreased proportions of CD3+CD8ab+ lympho-
cytes (which include only TCRab cells) in the gut mucosa,
but not in PB, when compared with wild-type mice.
Moreover, adoptive transfer of CD3+CD8ab+ thymocytes
from wild-type into CXCR3 deficient mice resulted in a
significant increase in CD3+CD8ab+ T cells in the gut, but not
in PB, spleen, or liver.
Thus taken together, these data suggest that
CXCR3+CD103+ TCRab+CD8+ SP thymocytes represent a
distinct subset of CD8ab+ T cells, at least in part already
equipped with the cytotoxic machinery, which may directly
migrate in response to CXCR3 binding chemokines constitu-
tively produced by epithelial cells into the gut mucosa where
they probably play an important role as a first line of
protection against infection and cell transformation.
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